Study #: 1984

Published: 11/2005

Pages: 228

Full Study Price: US$ 4,200

Per Page Price: US$ 30.00

Cancer Therapies to 2009 - Market Research, Market Share, Market Size, Sales, Demand Forecast, Market Leaders, Company Profiles, Industry Trends

US cancer therapies demand will grow ten percent annually through 2009. Gains will be driven by more incidence and detection of cancer coupled with a range of highly effective, but expensive, new treatments. Biotechnology-based therapies hold the best prospects. Outpatient facilities will be the fastest growing market.

This study analyzes the $16.8 billion US market for cancer therapies. It presents historical US demand data (1994, 1999 and 2004) and forecasts to 2009 and 2014 by cancer type (e.g., breast, digestive system, genital system, leukemia, lymphoma); by product/procedure (e.g., chemotherapy drugs, surgery, radiation therapy, biotechnology-based drugs, hormonal therapy, vaccines, nanotechnology, stem cells); and by institution/provider (e.g., hospitals, outpatient facilities, physicians’ offices, home health care).

The study also considers market environment trends and indicators, details industry composition and market share, and profiles 28 selected companies including Bristol Myers-Squibb, Merck, Pfizer, Amgen, Genentech, AstraZeneca, Roche Holding, Radiation Therapy Services, and US Oncology.

     TABLE OF CONTENTS
         INTRODUCTION
   I.    EXECUTIVE SUMMARY
  II.    MARKET ENVIRONMENT
         General
         Economic Environment
           Cyclical Trends
           Long-Term Trends
         Demographic Patterns
         Health Care Environment
           Health Insurance & Reimbursement
           Medical Conditions
              Acute Conditions
              Chronic Conditions
              Cancer Incidence & Indicators
           National Health Expenditures
           Medical Providers
           Pharmaceuticals Industry Overview
           Biotechnology Industry Overview
         Cost/Pricing Dynamics
         Regulatory Environment
         Multinational Dynamics
           World Cancer Therapies Market
           Trends in US Foreign Trade
  III.   TECHNOLOGY
         General
         Traditional Cancer Treatments
           Surgery
           Radiation
           Chemotherapy
         Advanced Cancer Therapies
           Biotechnology-Based
           Cancer Vaccines
           Nanotechnology-Based
           Stem Cells
         Chemotherapy Adjuvants
         Therapy Delivery Systems
         Other Technological Issues
           Cancer Screening & Imaging Systems
           Health Care Information Systems
  IV.    PRODUCTS & SERVICES
         General
         Therapies by Type of Cancer
           Breast
           Digestive System
           Genital System
           Leukemia
           Lymphoma
           Respiratory System
           Skin
           Urinary System
           Other
         Therapies by Product/Procedure
           Chemotherapy Drugs
              Mitotic Inhibitors
              Antimetabolites
              Alkylating Agents
              Other Types
           Surgery
           Radiation Therapy
           Biotechnology-Based Drugs
           Other/Advanced
              Hormonal Therapy
              Vaccines
              Nanotechnology
              Stem Cells & Other
   V.    MARKETS
         General
         Hospitals
           Market Overview
           Cancer Therapies Outlook
         Outpatient Facilities
           Market Overview
           Cancer Therapies Outlook
         Physicians  Offices
           Market Overview
           Cancer Therapies Outlook
         Other Markets
           Home Health Care
           Educational & Research Institutions
  VI.    INDUSTRY STRUCTURE
         General
         Industry Composition & Market Share
         Research & Product Development
         Manufacturing
         Marketing & Distribution
         Financial Issues & Requirements
         Mergers, Acquisitions & Industry Restructuring
         Strategic Partnerships
         Company Profiles